Newscenter Media News Phase II trial finds durvalumab plus ceralasertib boosted immune response and improved outcomes in patients with lung cancer. A specific combination of targeted therapy and…
Check Also
Binance expands crypto access in West, Central Africa with mobile money integration
Binance, a blockchain and cryptocurrency infrastructure provider has expanded access to cryptocurrency in Africa, as …